Transitional cell carcinoma of the urinary bladder following exposure to cyclophosphamide in childhood

Eur J Pediatr Surg. 2001 Jun;11(3):207-10. doi: 10.1055/s-2001-15486.

Abstract

With the increasing survival of children with malignancies, the long-term effects of chemotherapies are now becoming important and one of these dreadful long-term complications is the development of a second malignancy. Described here is a case of transitional cell carcinoma of the bladder developing 8 years following exposure to cyclophosphamide for the treatment of embryonal rhabdomyosarcoma.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antineoplastic Combined Chemotherapy Protocols
  • Bone Neoplasms / congenital
  • Bone Neoplasms / drug therapy*
  • Carcinoma, Transitional Cell / chemically induced*
  • Carcinoma, Transitional Cell / diagnostic imaging
  • Carcinoma, Transitional Cell / therapy
  • Combined Modality Therapy
  • Cyclophosphamide / adverse effects*
  • Cyclophosphamide / therapeutic use
  • Cystoscopy / methods
  • Dactinomycin
  • Follow-Up Studies
  • Humans
  • Male
  • Monitoring, Physiologic
  • Radiography
  • Radiotherapy, Adjuvant
  • Rhabdomyosarcoma / congenital
  • Rhabdomyosarcoma / drug therapy*
  • Time Factors
  • Treatment Outcome
  • Urinary Bladder Neoplasms / chemically induced*
  • Urinary Bladder Neoplasms / diagnostic imaging
  • Urinary Bladder Neoplasms / therapy
  • Vincristine

Substances

  • Dactinomycin
  • Vincristine
  • Cyclophosphamide

Supplementary concepts

  • VAC protocol